CreativeOne Wealth’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$976K Sell
10,893
-1,326
-11% -$109K 0.02% 588
2026
Q1
$968K Buy
12,219
+835
+7% +$67.5K 0.02% 592
2025
Q4
$935K Sell
11,384
-532
-4% -$41.2K 0.02% 576
2025
Q3
$833K Sell
11,916
-3,417
-22% -$231K 0.02% 614
2025
Q2
$983K Sell
15,333
-2,566
-14% -$159K 0.03% 540
2025
Q1
$1.14M Sell
17,899
-4,466
-20% -$300K 0.03% 440
2024
Q4
$1.49M Sell
22,365
-5,127
-19% -$353K 0.05% 355
2024
Q3
$1.92M Sell
27,492
-7,360
-21% -$510K 0.07% 276
2024
Q2
$2.26M Sell
34,852
-5,499
-14% -$348K 0.11% 183
2024
Q1
$2.61M Buy
40,351
+12,564
+45% +$818K 0.1% 179
2023
Q4
$1.83M Buy
27,787
+2,306
+9% +$134K 0.12% 172
2023
Q3
$1.45M Sell
25,481
-3,048
-11% -$186K 0.1% 184
2023
Q2
$1.75M Buy
28,529
+7,599
+36% +$474K 0.08% 236
2023
Q1
$1.31M Buy
20,930
+1,987
+10% +$128K 0.06% 261
2022
Q4
$1.2M Sell
18,943
-6,241
-25% -$396K 0.07% 257
2022
Q3
$1.48M Buy
+25,184
New +$1.55M 0.09% 199

Other funds holding PBE

CreativeOne Wealth's PBE Position: Q2 2026 in Review

CreativeOne Wealth reduced its Invesco Biotechnology & Genome ETF (PBE) stake by 11% in Q2 2026, selling an estimated $109K and leaving 10,893 shares worth $976K. The position accounts for 0.02% of the portfolio, ranked #588.

CreativeOne Wealth first reported a position in PBE in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.61M in Q1 2024. 105 funds tracked by Wall St. Rank hold PBE as of Q2 2026.

  • CreativeOne Wealth held 10,893 shares of Invesco Biotechnology & Genome ETF worth $976K as of Q2 2026.
  • CreativeOne Wealth sold 1,326 Invesco Biotechnology & Genome ETF shares in Q2 2026, an estimated $109K.
  • Invesco Biotechnology & Genome ETF made up 0.02% of CreativeOne Wealth's portfolio in Q2 2026, its #588 holding.
  • CreativeOne Wealth first reported a position in Invesco Biotechnology & Genome ETF in Q3 2022 and has held it in 16 quarters since.
  • CreativeOne Wealth's Invesco Biotechnology & Genome ETF position peaked at $2.61M in Q1 2024.
  • 105 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2026.

Based on CreativeOne Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.